ArticleThe journal of headache and pain2026
Forecasting migraine with time-series machine learning from mobile health data.
Article in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05616741 (A Randomized, Wait-list Controlled Trial of Daily, Home-based Biofeedback Therapy Using Cerebri for the Prevention of Migraine Attacks in Adults With Episodic Migraine), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized, Wait-list Controlled Trial of Daily, Home-based Biofeedback Therapy Using Cerebri for the Prevention of Migraine Attacks in Adults With Episodic Migraine
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMachine learning provides a powerful framework to model the complex patterns underlying migraine attack onset from real-world high dimensional datasets. In this study, we used machine learning to forecast headache days using mobile health (mHealth) data from a migraine biofeedback treatment app.
methodThis was a machine learning analysis of data from the BioCer clinical trial (NCT05616741) evaluating app-based biofeedback for preventive treatment of episodic migraine. Participants completed three months of daily biofeedback sessions with wearables measuring trapezius muscle tension, heart rate variability, and peripheral skin temperature. Input data for the models included summary metrics from the biofeedback sessions and daily headache diary entries. The outcome of interest was the presence of a moderate-to-severe headache (defined as an intensity of 4 or higher on an 11-point scale of 0-10) on the next calendar day and the next three calendar days. The dataset was randomly split into training, validation, and test sets. Multiple standard machine learning architectures, foundation models, and time-series models were trained and optimized using the area under the receiver operating characteristics curve (AUC) as the primary scoring metric. Among these three classes of machine learning models, the best optimized model in each class identified during training was applied on the unseen test set. Permutation feature importance (PFI) was created for model explainability.
results146 individuals, with a total of 21,550 headache days, were included in the forecasting models. For the next calendar day predictions, the top performing standard machine learning approach (decision tree) and foundation model achieved a test set AUC of 0.59 (95% CI 0.56 to 0.61) and 0.55 (95% CI 0.55 to 0.56), respectively. The best time-series model achieved a test set AUC of 0.84 (95% CI 0.82 to 0.85). For the three-calendar day forecasting window, the test set performances were 0.55 (95% CI 0.53 to 0.56), 0.55 (95% CI 0.54 to 0.57), and 0.76 (95% CI 0.74 to 0.77), respectively. The most important features were headache intensity, duration of the headache, and heart rate scores.
conclusionTime-series machine learning models using a relatively large dataset could forecast moderate-to-severe headaches with good accuracy in patients with episodic migraine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.